Exjade (deferasirox), breakthrough once-daily oral iron chelator, available in Korea

Exjade (deferasirox) is the first and only once-daily oral iron chelator for the treatment of iron overload in patients needing frequent blood transfusions for genetic blood disorders such as thalassaemia, sickle cell disease and other rare anaemias, according to a foreign honorable professor in a recent symposium.

In the symposium marking the launch of Exjade, which was organized by Novarti...